Guidelines for the management of chronic kidney disease.
作者信息
Levin Adeera, Hemmelgarn Brenda, Culleton Bruce, Tobe Sheldon, McFarlane Philip, Ruzicka Marcel, Burns Kevin, Manns Braden, White Colin, Madore Francoise, Moist Louise, Klarenbach Scott, Barrett Brendan, Foley Robert, Jindal Kailash, Senior Peter, Pannu Neesh, Shurraw Sabin, Akbari Ayub, Cohn Adam, Reslerova Martina, Deved Vinay, Mendelssohn David, Nesrallah Gihad, Kappel Joanne, Tonelli Marcello
机构信息
University of British Columbia, Vancouver, BC.
出版信息
CMAJ. 2008 Nov 18;179(11):1154-62. doi: 10.1503/cmaj.080351.
Abstract
摘要
相似文献
1
Guidelines for the management of chronic kidney disease.
CMAJ. 2008 Nov 18;179(11):1154-62. doi: 10.1503/cmaj.080351.
2
Progress and promise in the management of chronic kidney disease.
CMAJ. 2008 Nov 18;179(11):1107-8. doi: 10.1503/cmaj.081643.
3
Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.
Am J Kidney Dis. 2017 Nov;70(5):705-714. doi: 10.1053/j.ajkd.2017.06.025. Epub 2017 Aug 12.
4
Integration of peritoneal dialysis and adequacy beyond Kt/V.
Contrib Nephrol. 2003(140):209-17. doi: 10.1159/000071393.
5
Dialysis versus Medical Management at Different Ages and Levels of Kidney Function in Veterans with Advanced CKD.
J Am Soc Nephrol. 2018 Aug;29(8):2169-2177. doi: 10.1681/ASN.2017121273. Epub 2018 May 22.
6
GFR at initiation of dialysis and mortality in CKD: a meta-analysis.
Am J Kidney Dis. 2012 Jun;59(6):829-40. doi: 10.1053/j.ajkd.2012.01.015. Epub 2012 Apr 1.
7
A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease.
BMC Nephrol. 2008 Feb 25;9:3. doi: 10.1186/1471-2369-9-3.
8
Peritoneal dialysis as the first-choice treatment.
Contrib Nephrol. 2003(140):218-25. doi: 10.1159/000071394.
9
Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2012 Sep 1;80(3):352-7. doi: 10.1002/ccd.23394. Epub 2012 May 4.
10
When to start dialysis: theory, evidence and guidelines.
Contrib Nephrol. 2003(140):176-86. doi: 10.1159/000071389.
引用本文的文献
1
Relationship between Urine Protein-To-Creatinine Ratio and Leukocyte Esterase in Canine Urine Samples.
Vet Med Sci. 2025 Sep;11(5):e70532. doi: 10.1002/vms3.70532.
2
Role of vitamin D in the development and progression of diabetic kidney disease: an overview of meta-analyses.
Ther Adv Endocrinol Metab. 2025 Apr 26;16:20420188251319476. doi: 10.1177/20420188251319476. eCollection 2025.
3
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study.
BMC Infect Dis. 2025 Feb 25;25(1):275. doi: 10.1186/s12879-025-10643-w.
4
Global availability of medications and health technologies for kidney care: A multinational study from the ISN-GKHA.
PLOS Glob Public Health. 2025 Feb 10;5(2):e0004268. doi: 10.1371/journal.pgph.0004268. eCollection 2025.
5
Assessing the quality of CKD care using process quality indicators: A scoping review.
PLoS One. 2024 Dec 10;19(12):e0309973. doi: 10.1371/journal.pone.0309973. eCollection 2024.
6
Attitudes towards digital health technology for the care of people with chronic kidney disease: A technology acceptance model exploration.
PLOS Digit Health. 2024 Oct 9;3(10):e0000614. doi: 10.1371/journal.pdig.0000614. eCollection 2024 Oct.
7
Magnitude of multiple drug use and determinants of vulnerability among chronic kidney disease inpatients in Ethiopia: a multi-center study.
BMC Nephrol. 2024 Oct 7;25(1):332. doi: 10.1186/s12882-024-03773-x.
8
Reliability of the spot urine protein/creatinine ratio for assessing proteinuria in patients with renal disease.
J Int Med Res. 2024 Sep;52(9):3000605241281874. doi: 10.1177/03000605241281874.
9
Patients' acceptability of self-selected digital health services to support diet and exercise among people with complex chronic conditions: Mixed methods study.
Digit Health. 2024 Jun 7;10:20552076241245278. doi: 10.1177/20552076241245278. eCollection 2024 Jan-Dec.
10
Use of Wearable and Wireless Technology in Real-World Clinical Settings to Improve Patient Outcomes in Chronic Kidney Disease: A Mixed Methods Pilot Prospective Trial.
Can J Kidney Health Dis. 2023 Nov 21;10:20543581231212125. doi: 10.1177/20543581231212125. eCollection 2023.
本文引用的文献
1
Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.
Can J Diabetes. 2013 Apr;37 Suppl 1:S1-3. doi: 10.1016/j.jcjd.2013.01.009. Epub 2013 Mar 26.
2
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.
JAMA. 2007 Sep 19;298(11):1291-9. doi: 10.1001/jama.298.11.1291.
3
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.
Kidney Int. 2007 Aug;72(3):247-59. doi: 10.1038/sj.ki.5002343. Epub 2007 Jun 13.
4
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
Lancet. 2007 Feb 3;369(9559):381-8. doi: 10.1016/S0140-6736(07)60194-9.
5
The creation of an advance care planning process for patients with ESRD.
Am J Kidney Dis. 2007 Jan;49(1):27-36. doi: 10.1053/j.ajkd.2006.09.016.
6
Correction of anemia with epoetin alfa in chronic kidney disease.
N Engl J Med. 2006 Nov 16;355(20):2085-98. doi: 10.1056/NEJMoa065485.
7
Normalization of hemoglobin level in patients with chronic kidney disease and anemia.
N Engl J Med. 2006 Nov 16;355(20):2071-84. doi: 10.1056/NEJMoa062276.
8
The development of an Integrated Care Pathway for all patients with advanced life-limiting illness - the Supportive Care Pathway.
J Nurs Manag. 2006 Oct;14(7):521-8. doi: 10.1111/j.1365-2934.2006.00706.x.
9
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.
Can J Cardiol. 2006 Sep;22(11):913-27. doi: 10.1016/s0828-282x(06)70310-5.
10
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.
Can J Cardiol. 2006 May 15;22(7):583-93. doi: 10.1016/s0828-282x(06)70280-x.
Zotero 插件